A piecewise model of virus-immune system with two thresholds.
The combined antiretroviral therapy with interleukin (IL)-2 treatment may not be enough to preclude exceptionally high growth of HIV virus nor rebuilt the HIV-specific CD4 or CD8 T-cell proliferative immune response for management of HIV infected patients. Whether extra inclusion of immune therapy can induce the HIV-specific immune response and control HIV replication remains challenging. Here a piecewise virus-immune model with two thresholds is proposed to represent the HIV-1 RNA and effector cell-guided therapy strategies. We first analyze the dynamics of the virus-immune system with effector cell-guided immune therapy only and prove that there exists a critical level of the intensity of immune therapy determining whether the HIV-1 RAN virus loads can be controlled below a relative low level. Our analysis of the global dynamics of the proposed model shows that the pseudo-equilibrium can be globally stable or locally bistable with order 1 periodic solution or bistable with the virus-free periodic solution under various appropriate conditions. This indicates that HIV viral loads can either be eradicated or stabilize at a previously given level or go to infinity (corresponding to the effector cells oscillating), depending on the threshold levels and the initial HIV virus loads and effector cell counts. Comparing with the single threshold therapy strategy we obtain that with two thresholds therapy strategies either virus can be eradicated or the controllable region, where HIV viral loads can be maintained below a certain value, can be enlarged.
School of Mathematics and Statistics, Xi'an Jiaotong University, Xi'an 710049, PR China; Centre for Disease Modelling, York Institute for Health Research, York University, Toronto, ON M3J 1P3, Canada.
Biao
B
Tang
School of Mathematics and Statistics, Xi'an Jiaotong University, Xi'an 710049, PR China. Electronic address: yxiao@mail.xjtu.edu.cn.
Yanni
Y
Xiao
Centre for Disease Modelling, York Institute for Health Research, York University, Toronto, ON M3J 1P3, Canada.
Jianhong
J
Wu
D044966:Anti-Retroviral Agents / Q000627:therapeutic use*; D015658:HIV Infections / Q000276:immunology* / Q000628:therapy* / Q000821:virology*; D015497:HIV-1 / Q000276:immunology*; D006801:Humans; D007167:Immunotherapy; D008962:Models, Theoretical
D044966:Anti-Retroviral Agents
Global dynamics; HIV; Piecewise model; Structured treatment interruptions; Two thresholds